1. Home
  2. ATYR vs EPSN Comparison

ATYR vs EPSN Comparison

Compare ATYR & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$4.59

Market Cap

132.1M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
EPSN
Founded
2005
2005
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
132.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
EPSN
Price
$0.73
$4.59
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.2M
125.8K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
5.47%
EPS Growth
N/A
11.33
EPS
N/A
0.27
Revenue
$190,000.00
$45,709,605.00
Revenue This Year
N/A
$41.35
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$17.09
Revenue Growth
N/A
46.76
52 Week Low
$0.64
$4.36
52 Week High
$7.29
$8.50

Technical Indicators

Market Signals
Indicator
ATYR
EPSN
Relative Strength Index (RSI) 41.71 39.92
Support Level $0.70 $4.76
Resistance Level $0.83 $5.09
Average True Range (ATR) 0.05 0.18
MACD 0.01 -0.02
Stochastic Oscillator 26.75 1.82

Price Performance

Historical Comparison
ATYR
EPSN

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

Share on Social Networks: